(5R)-BW-4030W92: Unlocking the Potential of Sodium Channel Modulation

(5R)-BW-4030W92, with the CAS number 189013-61-4, is a remarkable chemical compound that holds immense promise in the realm of neurological research and drug development. As the R-type of the BW-4030W92 molecule, this non-selective, voltage-dependent, and use-dependent sodium channel antagonist offers a unique opportunity to explore the intricate workings of the nervous system and uncover potential treatments for a wide range of neurological disorders.

At the heart of (5R)-BW-4030W92's significance lies its ability to modulate the activity of sodium channels, which play a crucial role in the generation and propagation of electrical signals within the body. By acting as an antagonist, this compound can effectively regulate the flow of sodium ions, potentially influencing neuronal excitability and synaptic transmission. This mechanism of action opens up avenues for researchers to investigate the underlying causes and potential therapeutic interventions for conditions such as epilepsy, chronic pain, and even neurodegenerative diseases.

Purity and Chemical Characteristics

Meticulously synthesized to a purity of 98%, (5R)-BW-4030W92 is a solid compound with the molecular formula C11H9Cl2FN4 and a molecular weight of 287.12 g/mol. Its distinct chemical structure, featuring chlorine, fluorine, and nitrogen-containing functional groups, contributes to its unique pharmacological properties and potential applications.

Versatile Applications in Neurological Research

The versatility of (5R)-BW-4030W92 extends beyond its role as a sodium channel antagonist. Researchers in the field of neuroscience have recognized its value as a valuable tool for investigating the underlying mechanisms of various neurological disorders. By modulating the activity of sodium channels, this compound can provide insights into the pathophysiology of conditions such as:

• Epilepsy: (5R)-BW-4030W92's ability to influence neuronal excitability makes it a promising candidate for studying the mechanisms behind seizure activity and exploring potential anti-epileptic therapies.
• Chronic Pain: As a sodium channel antagonist, (5R)-BW-4030W92 may hold the key to understanding the role of these channels in the transmission and perception of pain signals, potentially leading to the development of novel analgesic treatments.
• Neurodegenerative Diseases: Researchers can leverage (5R)-BW-4030W92 to investigate the involvement of sodium channels in the pathogenesis of neurodegenerative conditions, such as Alzheimer's disease or Parkinson's disease, opening up new avenues for therapeutic interventions.

Ensuring Optimal Storage and Handling

To maintain the integrity and purity of (5R)-BW-4030W92, it is essential to adhere to proper storage and handling protocols. The compound should be stored at low temperatures, preferably at -20°C for up to 3 years in its powder form or -80°C for up to 1 year when dissolved in a suitable solvent. This careful approach ensures the compound's stability and reliability in research applications.

Unlocking the Potential of Sodium Channel Modulation

As a highly purified and well-characterized chemical compound, (5R)-BW-4030W92 stands as a valuable asset in the pursuit of understanding and treating neurological disorders. Its unique ability to modulate sodium channel activity opens up a world of possibilities for researchers, from unraveling the complexities of the nervous system to developing innovative therapeutic strategies. By leveraging the power of this versatile compound, scientists can unlock new frontiers in the field of neuroscience, paving the way for groundbreaking advancements that can profoundly impact the lives of those affected by neurological conditions.